title: Effect of iron on transferrin receptor expression by human placental syncytiotrophoblast cells.
abstract: Transferrin receptor expression has been examined in primary cultures of morphologically differentiated placental syncytiotrophoblast cells. More than 90% of the cells were multinucleated. Incubation of syncytiotrophoblast for 4 days in the presence of iron salts had no effect on receptor expression assessed by measuring the binding of 125I-labelled transferrin. However, incubation of cells in the presence of human diferric transferrin (10-100 microM) led to a 50% decrease in surface and intracellular receptor expression. This down-regulation was not accompanied by a significant decrease in receptor synthesis. In contrast to syncytiotrophoblast, expression of intracellular transferrin receptors in non-differentiated cytotrophoblast cells decreased when cells were cultured with iron salts; this was accompanied by decreased receptor synthesis. Addition of diferric transferrin to cytotrophoblast cells led to a 50% reduction in surface and intracellular receptor expression, similar to that seen in the syncytiotrophoblast. This reduction was accompanied by a decrease in receptor synthesis. In contrast to that of most cell types, the expression and distribution of trophoblast transferrin receptors were not altered by insulin, epidermal growth factor or hydrocortisone. These characteristics of syncytiotrophoblast transferrin receptor expression may assist in ensuring a supply of iron to the fetus regardless of the maternal iron status.
authors.affiliation: Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis 95616-8643, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Kennedy
authors.forename: G C
authors.initials: GC
authors.lastname: Douglas
authors.forename: B F
authors.initials: BF
authors.lastname: King
mesh_terms: D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D007501:Iron / Q000494:pharmacology*; D011247:Pregnancy; D011990:Receptors, Transferrin / Q000096:biosynthesis / Q000235:genetics*; D014168:Transferrin / Q000494:pharmacology; D014327:Trophoblasts / Q000378:metabolism*
chemical_list: D007328:Insulin; D011990:Receptors, Transferrin; D014168:Transferrin; C028283:diferric transferrin; D004815:Epidermal Growth Factor; D007501:Iron; D006854:Hydrocortisone